Loading provider…
Loading provider…
Pediatric Infectious Diseases Physician in Omaha, NE
NPI: 1265548762Primary Employer
Chi St. Alexius Health Clinics
chistalexiushealth.org
HQ Phone
Get M.D. Meera's Phone NumberMobile
Get M.D. Meera's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNE State Medical License
ID State Medical License
CA State Medical License
2024 - 2026
FL State Medical License
2024 - 2026
GA State Medical License
2025 - 2026
ID State Medical License
2024 - 2026
ND State Medical License
2024 - 2026
NE State Medical License
2000 - 2026
TX State Medical License
2024 - 2026
MN State Medical License
2024 - 2025
AL State Medical License
1995 - 2000

American Board of Pediatrics
Pediatrics

American Board of Pediatrics
Pediatric Infectious Diseases
USA Health
Residency • Pediatrics
1994 - 1997
Coimbatore Medical College
Medical School
Until 1986
Immunizations for patients with metabolic disorders.
Authors: Deborah Yokoe, Aaron Milstone, Marci Drees, Manisha Juthani-Mehta, Danielle Zerr, Jennifer Meddings, Loren Miller, Darren Linkin, Ebbing Lautenbach, Curtis Donskey, Stuart Cohen
Journal: Infect Control Hosp Epidemiol
Authors: Olsson, Sven-Eric, Restrepo, Jaime Alberto, Reina, Julio Cesar, Pitisuttithum, Punnee, Ulied, Angels, Varman, Meera, Van Damme, Pierre, Moreira, Edson Duarte, Ferris, Daron, Block, Stanley, Bautista, Oliver, Gallagher, Nancy, McCauley, Jennifer, Luxembourg, Alain
Journal: Papillomavirus Res
Publication Date: 2020-07-11
Lead Sponsor: GlaxoSmithKline
Intervention / Treatment: BIOLOGICAL: Varivax, BIOLOGICAL: Bexsero (GSK Biologicals' Meningococcal group-B vaccine/ rMenB+OMV NZ), BIOLOGICAL: Prevnar13, BIOLOGICAL: Pediarix, BIOLOGICAL: Hiberix, BIOLOGICAL: Rotarix, BIOLOGICAL: M-M-R II, BIOLOGICAL: Placebo (saline water), BIOLOGICAL: Prevnar 20
Lead Sponsor: Regeneron Pharmaceuticals
Intervention / Treatment: DRUG: Suptavumab 30 mg/kg - 2 Doses, DRUG: Suptavumab 30 mg/kg, DRUG: Placebo Matched to Suptavumab, DRUG: Suptavumab 30 mg/kg- 1 Dose